Intermittent Dosage in the Treatment of Pulmonary Tuberculosis with Streptomycin

John Bignall, J. W. Clegg, John Crofton, Beverly Douglas, H. D. Holt, D A Mitchison, P. Armitage

BMJ · 1950 · 18 citations · 1 references

DOIFull text

Open access

Concepts

Abstract

The emergence of drug-resistant tubercle bacilli has been the major difficulty in the streptomycin treatment of pul- monary tuberculosis. In the first Medical Research Council series of cases of pulmonary tuberculosis treated in this country (Medical Research Council, 1 948a) strains showing a streptomycin resistance more than 10 times that of the control were isolated from 35 out of 41 cases. The resistant organisms were usually first found within two months of beginning treatment, occasionally later. Towards the end of 1947, when the first trial was finishing, it was already obvious that any way of avoiding or delaying the emergence of resistance would be a major advance.

References

1